86 related articles for article (PubMed ID: 366836)
1. An HLA-D-linked low response to polyclonal B-cell activation in multiple sclerosis.
Paty DW; Cousin HK; Stiller CR; Dossetor JB
Transplant Proc; 1978 Dec; 10(4):973-5. PubMed ID: 366836
[No Abstract] [Full Text] [Related]
2. Elevated direct and IgM enhanced ADCC activity in multiple sclerosis patients.
Merrill JE; Wåhlin B; Sidén A; Perlmann P
J Immunol; 1982 Apr; 128(4):1728-35. PubMed ID: 7037955
[No Abstract] [Full Text] [Related]
3. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
[TBL] [Abstract][Full Text] [Related]
4. The effects of mitogen-stimulated T cells on the response of B cell to antigen and the mechanism of T cell stimulation and of the B cell response.
Dutton RW; Hunter P
Soc Gen Physiol Ser; 1974; 29():199-215. PubMed ID: 4610763
[No Abstract] [Full Text] [Related]
5. Immunology of multiple sclerosis.
Oger J; Roos R; Antel JP
Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
[TBL] [Abstract][Full Text] [Related]
6. Heavy chain isotype suppression: a review of the immunosuppressive effects of heterologous anti-Ig heavy chain antisera.
Manning DD
J Reticuloendothel Soc; 1975 Jul; 18(1):63-86. PubMed ID: 807728
[No Abstract] [Full Text] [Related]
7. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
[TBL] [Abstract][Full Text] [Related]
8. The mononuclear phagocyte system: the heart of host defense.
Blaese RM; Muchmore AV
Mead Johnson Symp Perinat Dev Med; 1986; (24):13-5. PubMed ID: 3091969
[No Abstract] [Full Text] [Related]
9. [Locus HLA-DR--specific antigens of B lymphocytes. Comprehensive review].
Májský A
Vnitr Lek; 1978 Nov; 24(11):1092-1101. PubMed ID: 82296
[No Abstract] [Full Text] [Related]
10. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
11. B lymphocyte response as an indicator of acute renal transplant rejection. II. Pretransplant and posttransplant B cell responses of m mitogen and donor cell-stimulated cultures.
Weimer R; Daniel V; Pomer S; Opelz G
Transplantation; 1989 Oct; 48(4):572-5. PubMed ID: 2678634
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell activity in multiple sclerosis.
Hauser SL; Ault KA; Levin MJ; Garovoy MR; Weiner HL
J Immunol; 1981 Sep; 127(3):1114-7. PubMed ID: 6167616
[No Abstract] [Full Text] [Related]
13. Biologic activity of antigen receptors artificially incorporated onto B lymphocytes.
Peacock JS; Londo TR; Roess DA; Barisas BG
J Immunol; 1986 Sep; 137(6):1916-23. PubMed ID: 2427584
[TBL] [Abstract][Full Text] [Related]
14. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.
Hirschberg H; Moen T; Thorsby E
Transplant Proc; 1979 Mar; 11(1):776-8. PubMed ID: 377711
[No Abstract] [Full Text] [Related]
15. Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes.
Taylor DS; Nowell PC; Kornbluth J
J Immunol; 1987 Sep; 139(6):1792-6. PubMed ID: 3497978
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunology in multiple sclerosis. A review through 1984.
Baumhefner RW; Tourtellotte WW
Concepts Immunopathol; 1985; 2():151-88. PubMed ID: 2439204
[No Abstract] [Full Text] [Related]
17. Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.
Bird AG; Hammarström L; Smith CI; Britton S
Clin Exp Immunol; 1981 Jan; 43(1):165-73. PubMed ID: 6454516
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of DR xenoantisera in a cytotoxic test with human complement.
Belvedere M; Olivetti E; Pellegrino MA; Ferrone S
Transplant Proc; 1979 Jun; 11(2):1327-8. PubMed ID: 314179
[No Abstract] [Full Text] [Related]
19. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
Ono S; Takahama Y; Hamaoka T
J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
